Yahoo · Oct 27, 2026
What to expect from CONMED’s (CNMD) Q3 earnings
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings this Wednesday after the bell. Here’s what you need to know.
CN
NASDAQ · CNMD
CONMED Corporation
Healthcare · Medical - Devices
$45.72
Down-$0.40 (-0.87%)
Updated Oct 30, 2026, 4:07 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.23B
- P/E ratio
- 11.17
- Dividend yield
- 1.75%
- 52-week range
- $31.44 – $53.66
- Volume
- 482.19K
- Avg. volume
- 469.39K
Price performance · CNMD
CNMD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
CNMD closed at $45.72 after 21 trading sessions, down 0.46% for the selected period.
- Last close
- $45.72
- Period change
- -0.46%
- Period low
- $44.23
- Period high
- $49.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $43.60 | $46.47 | $43.50 | $45.72 | 482.19K |
| Oct 28, 2026 | $47.40 | $48.09 | $45.12 | $45.76 | 610.18K |
| Oct 27, 2026 | $48.09 | $48.09 | $46.53 | $47.20 | 505.95K |
| Oct 26, 2026 | $48.78 | $49.73 | $47.56 | $47.68 | 386.61K |
| Oct 23, 2026 | $49.03 | $49.72 | $48.31 | $49.25 | 343.26K |
| Oct 22, 2026 | $47.38 | $49.56 | $47.38 | $49.44 | 398.58K |
| Oct 21, 2026 | $46.92 | $47.80 | $46.54 | $47.11 | 442.96K |
| Oct 20, 2026 | $45.815 | $48.00 | $45.815 | $47.58 | 440.15K |
| Oct 19, 2026 | $46.49 | $47.06 | $45.89 | $46.05 | 342.34K |
| Oct 16, 2026 | $47.32 | $47.80 | $46.50 | $46.72 | 413.97K |
| Oct 15, 2026 | $45.59 | $47.85 | $44.89 | $47.14 | 401.29K |
| Oct 14, 2026 | $45.23 | $46.59 | $44.53 | $44.93 | 392.39K |
| Oct 13, 2026 | $45.59 | $46.09 | $44.09 | $45.55 | 521.74K |
| Oct 12, 2026 | $44.96 | $45.45 | $44.18 | $45.36 | 515.22K |
| Oct 9, 2026 | $44.89 | $45.66 | $44.145 | $44.42 | 400.45K |
| Oct 8, 2026 | $44.32 | $45.43 | $44.05 | $45.11 | 473.96K |
| Oct 7, 2026 | $44.07 | $44.6425 | $43.97 | $44.23 | 521.29K |
| Oct 6, 2026 | $47.83 | $48.25 | $44.31 | $44.48 | 456.37K |
| Oct 5, 2026 | $46.43 | $47.77 | $46.11 | $47.33 | 343.34K |
| Oct 2, 2026 | $46.88 | $47.06 | $46.1601 | $46.32 | 240.74K |
| Oct 1, 2026 | $46.18 | $46.59 | $45.73 | $45.93 | 222.4K |
Latest CNMD news
The latest Smart Investors Daily articles mentioning CNMD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
CNMD research
Overview
Company profile and research snapshot.
Company profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $78.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 29, 2026 | JP Morgan | Neutral | — |
| Oct 29, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 30, 2026 | Piper Sandler | Neutral | — |
| Jul 30, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 16, 2026
3 Low-Volatility Stocks with Questionable Fundamentals
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Yahoo · Oct 2, 2026
Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers.
Yahoo · Oct 1, 2026
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
LARGO, Fla., October 01, 2026--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
